In the Journals

Spironolactone use for acne increases

July 10, 2017
There was a significant increase in the use of spironolactone as therapy for patients with acne by both dermatologists and nondermatologists between…

In the Journals

Costs for acne, rosacea prescriptions for Medicare patients higher with specialists vs. PCPs

July 5, 2017
Prescription costs for acne and rosacea medications for Medicare patients were higher from specialists compared with primary care physicians in…

Foamix Pharmaceuticals names new CEO

July 3, 2017
Foamix Pharmaceuticals Ltd. recently announced that its board of directors has named David Domzalski as CEO, effective immediately. Domzalski…

Meeting News

Patients with acne report positive experience with minocycline gel

June 26, 2017
BioPharmX Corp. recently presented results of its phase 2b study of BPX-01 for treating moderate-to-severe acne vulgaris showing that patients…

Meeting News

PCPs, NPs, 'have responsibility' to inform patients of less expensive medications

June 22, 2017
PHILADELPHIA — Primary care physicians need to play a more active role in helping their patients get the best price for medications, according…

FDA News

FDA orders dermatological drug manufacturer and distributor to cease operations

June 15, 2017
United States District Judge Kathleen M. Williams for the Southern District of Florida issued a consent decree of permanent injunction against…

BioPharmX reports Q1 results, acne treatment update

June 14, 2017
BioPharmX Corporation reported financial results for the first quarter ending April 30, as well as an update on BPX-01, its investigational topical…

BPX-01 2% reduced acne lesions by 59%

June 1, 2017
BioPharmX Corporation announced comprehensive phase 2b clinical data results that showed  BPX-01 2% reduced the number of inflammatory lesions…

Madenco Biosciences announces cosmeceuticals for treating acne scars, laser effects

May 18, 2017
Madenco Biosciences, a subsidiary of Quest PharmaTech, announced it has created a new line of cosmeceuticals targeting applications by dermatologist…

Foamix plans third phase 3 trial for minocycline foam to treat acne with NDA as goal

May 10, 2017
Foamix Pharmaceutical recently announced that based on the results of its first two phase 3 trials, it will conduct a third U.S. phase 3 trial of…

Valeant Q1 financial report includes Siliq, Bausch + Lomb news

May 9, 2017
Valeant Pharmaceuticals International announced first quarter financial results, including a reduction of debt of $1.3 billion in the first quarter…

BPX-01 topical minocycline shows efficacy in treating acne

May 4, 2017
BioPharmX announced that BPX-01 showed efficacy in both 1% and 2% doses in treating moderate-to-severe acne in children and adults. BPX-01 is a…

Sienna Biopharmaceuticals announces financing for dermatologic therapies

April 26, 2017
Sienna Biopharmaceuticals announced it has completed a $40 million, Series B financing to advance its diversified topical biotech pipeline. The…

TopMD appoints dermatologist to board of directors

April 19, 2017
TopMD announced that Jerald Sklar, MD, has been appointed to its board of directors. Sklar is a dermatologist in private practice in Dallas, and…

Dermata, Villani to develop natural sponge product to treat acne

April 13, 2017
Dermata Therapeutics and Villani announced they have entered into an exclusive global license agreement for Dermatta to develop Villani's natural…

Newly FDA-approved dermal laser systems launched

April 10, 2017
Synergy MedSales has announced it has signed an agreement with FormaTK Systems Ltd. to market and distribute FormaTK’s latest FDA-approved…

PhotoSonix Medical appoints Steele as executive chairman

April 10, 2017
PhotoSonix Medical announced it has appointed Mark D. Steele as executive chairman of the company. Steele recently joined the board of directors of…

Vitiligo study tops week's dermatology reads

April 10, 2017
Study findings that autoimmune thyroid diseases and thyroid cancer were significantly associated with vitiligo was a top-read article of the past…

In the Journals

Isotretinoin for acne not associated with increased depression risk

April 5, 2017
Isotretinoin treatment for acne was not associated with an increased risk for depression, according to recent research published in the Journal of

Eichenfield to chair Novan dermatology advisory council

April 4, 2017
Novan announced it has formed an advisory council comprised of key opinion leaders in the field of dermatology, which will be led by…

Healio Jobs